PLAA 抗体 (AA 101-200)
-
- 抗原 See all PLAA 抗体
- PLAA (Phospholipase A2-Activating Protein (PLAA))
-
抗原表位
- AA 101-200
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This PLAA antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- 预测反应
- Human,Mouse,Rat,Dog,Cow,Pig,Horse,Rabbit
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from human Phospholipase A2 activator protein
- 亚型
- IgG
- Top Product
- Discover our top product PLAA Primary Antibody
-
-
- 应用备注
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- 有效期
- 12 months
-
-
Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients." in: Atherosclerosis, Vol. 230, Issue 1, pp. 164-70, (2013) (PubMed).
: "
-
Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients." in: Atherosclerosis, Vol. 230, Issue 1, pp. 164-70, (2013) (PubMed).
-
- 抗原
- PLAA (Phospholipase A2-Activating Protein (PLAA))
- 别名
- PLAA/Phospholipase A2 activator protein (PLAA 产品)
- 别名
- cb623 antibody, zgc:56568 antibody, zgc:66193 antibody, wu:fc45d08 antibody, wu:fi33e06 antibody, PLAA antibody, doa1 antibody, pla2p antibody, plap antibody, DOA1 antibody, PLA2P antibody, PLAP antibody, 2410007N06 antibody, AI536418 antibody, AU018445 antibody, AW208417 antibody, D4Ertd618e antibody, Ufd3 antibody, Plap antibody, phospholipase A2-activating protein antibody, phospholipase A2 activating protein antibody, phospholipase A2-activating protein L homeolog antibody, phospholipase A2-activating protein S homeolog antibody, phospholipase A2, activating protein antibody, plaa antibody, PLAA antibody, plaa.L antibody, plaa.S antibody, Plaa antibody
- 背景
-
Synonyms: DOA1, PLAP, PLA2P, Phospholipase A-2-activating protein, PLAA
Background: Phospholipase A2 activator protein (PLAP), activates PLA2 (phospholipase A2 enzyme) and is an important mediator of eicosanoid generation. Also known as a pro-inflammatory agent, PLAP has been found in inflamed tissues and synovial fluid from patients with rheumatoid arthritis. As such, it is believed to play an important role in the regulation of inflammatory diseases. The formation of PLAP can be stimulated by IL-1 beta and TNF-alpha.
- 基因ID
- 9373
- UniProt
- Q9Y263
-